Literature DB >> 20589628

Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.

In-sang Jeon1, Sang Seon Lee, Min Kyung Lee.   

Abstract

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis of an unknown origin. The prognosis of ECD is variable, and it mainly depends on the involved anatomic sites. The treatment modalities have not been standardized. Interferon-alpha (IFN) has been reported to be effective in the management of ECD. We report here on an uncommon case with ECD in a 17-year-old female who had multiple lesions in the whole body and she was treated with chemotherapy and IFN. She has remained disease-free for 2 years after the completion of treatment. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20589628     DOI： 10.1002/pbc.22636

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  6 in total

1.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  The clinical spectrum of Erdheim-Chester disease: an observational cohort study.

Authors:  Juvianee I Estrada-Veras; Kevin J O'Brien; Louisa C Boyd; Rahul H Dave; Benjamin Durham; Liqiang Xi; Ashkan A Malayeri; Marcus Y Chen; Pamela J Gardner; Jhonell R Alvarado-Enriquez; Nikeith Shah; Omar Abdel-Wahab; Bernadette R Gochuico; Mark Raffeld; Elaine S Jaffe; William A Gahl
Journal:  Blood Adv       Date:  2017-02-14

Review 3.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

4.  Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Anat Kesler; Orna Aizenstein; Iris Eshed; Ronald Jaffe; Yakov Pessach; Ilan Goldberg; Eli Sprecher; Iris Yaish; Alexander Gural; Chezi Ganzel; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2014-12-01       Impact factor: 8.775

5.  A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge.

Authors:  Hamza Hashmi; Drew Murray; John Greenwell; Marwan Shaikh; Soumit Basu; Maxwell Krem
Journal:  Case Rep Hematol       Date:  2018-05-16

6.  A Rare Case of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome.

Authors:  Shahzaib Nabi; Adeel Arshad; Tarun Jain; Fawad Virk; Rohit Gulati; Rana Awdish
Journal:  Case Rep Pathol       Date:  2015-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.